PDB40 COST-UTILITY ANALYSIS IN A USA SETTING OF SCREENING AND OPTIMIZED TREATMENT OF NEPHROPATHY IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES
Abstract
Authors
AJ Palmer R Chen WJ Valentine S Roze S Gabriel N Mehin B Bregman R Rodby